We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.25 | 5.15% | 25.50 | 25.00 | 26.00 | 25.50 | 23.75 | 24.25 | 233,146 | 16:04:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.19M | -0.0469 | -5.44 | 17.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2024 04:42 | Sareum have been missing deadlines for 20 years. If you do your own due diligence in particular getting 1801 to clinic the delays are extraordinary. As I said earlier why is their phase 1 Protocol taking so long just for Safety? There products are too old, that is why the MHRA refused Sareum a Phase 1 CTA (Clinical Trial Authorisation) despite the fact that an external & experienced Consultancy (CRO) had developed the novel capsule technology for them. I suspect the MHRA may have felt that the novel formulation is not a sufficient innovation to expose fit and healthy volunteer-patients to the risks of the trial. Going to the Australian Regulator Authority Sareum is hoping to use their diminishing financial resources to show that their prototype drug is safe enough to administer to sick patients in the future (Phase 2a and then Phase 2b). This is now in doubt IMHO? And how are they going to pay for it? Suffice to say this looks to me like the last throw of the dice for Sareum. | peaceandlove | |
09/5/2024 22:49 | Sareum attending Bio International 2024 another Red Flag to add to the ever growing list no one is queuing up to license their decade old Tyk2 Jak1 which must now rank as last in class and worst in class | iamhappy1 | |
09/5/2024 21:04 | SGH throwing his weight around in my absence I see! A senior moment perhaps? I can actually picture him saying "The mask is slipping sonny" Closely followed by "Pull it back up or I'll lose my erection" It's not a nice image. Was it one of those fancy dress doggy masks? Or don't they come in kids sizes? | cubanpete | |
09/5/2024 17:21 | Homophobia again. The mask is slipping Sonny. | silvergreyhead1 | |
09/5/2024 16:36 | Time to sign out of the Peace login and bring Woolfie back for the rest of the day.Bad day at the office for you today Sonny.Ah well. | silvergreyhead1 | |
09/5/2024 16:29 | Dear LTHs (happy clappers).....I think the time has come to accept that Tim and co are struggling to bring their vision to fruition. I am basing this statement on nothing concrete but simply on pure sentiment. The market has reacted in exactly the same way as it always does when emotion overrides dispassionate analysis.......stagn | peaceandlove | |
09/5/2024 16:21 | LMFAO I own you - feeking nutters all of you. I own you lol 😜 You can't answer my questions because you're not capable. It's a chat forum - no one owns anyone. Ffs 🤦🏻 Silver, you're unimaginative and a dull-witted man individual. Now run along back to LSE and hide behind Sadoldgit LMFAO, at you idiots 🤣 Peace and Love ✌️ | peaceandlove | |
09/5/2024 16:06 | Come on sonny you have been well and truly owned today.Take it on the chin sonny. | silvergreyhead1 | |
09/5/2024 15:50 | 😂😂 peaceandlove 🤥 - | norma_stitts | |
09/5/2024 13:47 | What you on about? I sold out in June 2021. LMFAO | peaceandlove | |
09/5/2024 13:06 | Peaceandlove - “you DO NOT understand how investing works” you’re having a go at comedy as well. Btw - are these your posts, a friend tells me they are. lol “13981 - If they pull this off we'll indeed be quids in. 14000 - Personally I don't care - I've a decent holding and will hold until it's over.” | barkbooo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions